Johnson&Johnson claims to have resolved some of the talc powder claims
水色草莓慷
发表于 2023-12-6 16:25:13
1325
0
0
Erik Haas, the global vice president in charge of litigation at Johnson&Johnson, stated during an investor conference call on December 5th local time that the company has recently reached a settlement with several law firms regarding their client's claim that Johnson&Johnson's talc powder products are carcinogenic.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Johnson&Johnson will pay $6.5 billion to resolve a talcum powder cancer lawsuit
- Kenvue, Global layoffs: Johnson&Johnson plans to clear its holdings, raise prices to sustain sales, and it is difficult to maintain sales
- Johnson&Johnson plans to acquire biotech company Proteology for $850 million
- Is Johnson&Johnson clearing Kenvue shares and withdrawing from the skincare and beauty industry a win-win situation or a last resort?
- Qiangsheng subsidiary responds to "shortage of focus in Daduo": the company faces supply pressure and challenges due to a significant increase in market demand
- Johnson&Johnson appoints Zhou Mintao as President of Medical Technology China
- Johnson&Johnson China completes business changes, with Song Weiqun stepping down as chairman
- Johnson&Johnson China CEO Song Weiqun steps down as Chairman of Johnson&Johnson China
- Citigroup raises Johnson&Johnson's target price from $180 to $185
- Johnson&Johnson China's multiple product lines have been exposed to layoffs! An employee reported a layoff scale of 20%
